L Brands Reports Third Quarter 2018 Results
— PROVIDES FOURTH QUARTER GUIDANCE — — PLANS TO REDUCE 2019 ANNUAL DIVIDEND TO $1.20 PER SHARE — — ANNOUNCES VICTORIA’S SECRET LINGERIE […]
FutureFuel Corp. Declares Quarterly Dividend Program for 2019
CLAYTON, Mo., Nov. 19, 2018 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals […]
Apergy to Present at the Jefferies Energy Conference
THE WOODLANDS, Texas, Nov. 19, 2018 (GLOBE NEWSWIRE) — Apergy Corporation (“Apergy”) (NYSE: APY), announced today that Sivasankaran “Soma” Somasundaram, […]
GWG Holdings Reports Results for the Third Quarter Ended September 30, 2018
GWGH Announces share repurchase program MINNEAPOLIS, Nov. 19, 2018 (GLOBE NEWSWIRE) — GWG Holdings, Inc. (Nasdaq:GWGH), a leading provider of […]
XOMA Announces Commencement of Rights Offering
EMERYVILLE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has […]
Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule and Intention to Initiate Patient Studies in Multiple Indications in Collaboration With Sanofi
Phase 1 healthy volunteer study of DNL747 meets all endpoints, including CSF exposure levels, RIPK1 inhibition, and pathway engagement, at […]
Progenics Pharmaceuticals Announces Presentation of Updated Safety and Tolerability Data for AZEDRA® (iobenguane I 131) at the Radiological Society of North America (RSNA) Annual Meeting
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), an oncology company developing innovative medicines and […]
Prudential Bancorp, Inc. Announces Declaration of Dividend and Adoption of New Stock Repurchase Program
PHILADELPHIA, Nov. 19, 2018 (GLOBE NEWSWIRE) — Prudential Bancorp, Inc. (the “Company”) (Nasdaq: PBIP) announced that its Board of Directors, […]
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus
GAITHERSBURG, Md. and SAINT-HERBLAIN, France, Nov. 19, 2018 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) and Valneva SE (VLA) […]
Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference
CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on […]
